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In this issue of Structure, Xiao et al. (2015) describe a newmechanism of regulation of lipid binding. Structural
and functional studies demonstrate that Tom1 interactions with the cargo sorting protein Tollip induce the
partially unfolded Tom1-binding domain of Tollip to fold. This folding modulates lipid binding of Tollip, medi-
ating its dissociation from PI(3)P and committing Tollip to cargo trafficking.Trafficking of cargo across the outer
plasma membrane of eukaryotic cells re-
quires a collection of biochemical and
biophysical changes to lipids and pro-
teins. The plasma membrane is morphed
into a trafficking vesicle to sort cargo to
different cellular destinations. Endocy-
tosis, which is the process of forming a
lipid-enveloped vesicle from the plasma
membrane, requires several important
protein modifications including ubiquity-
lation. Lipid metabolism of cellular phos-
phoinositides also plays an important
role in these processes. Cargo is sorted
into different trafficking compartments,
such as early endosomes (Platta and
Stenmark, 2011), which directly arise
from the endocytosis process or later
sorting into late endosomes and multive-
sicular bodies. While the key binding do-
mains that regulate these protein-protein
and lipid-protein interactions are known,
many of the structural details that regulate
protein handoff and sorting are unknown.
The early endosomes, which contain
the lipid marker phosphatidylinositol-3-
phosphate [PI(3)P] in their cytoplasmic
leaflet (Gillooly et al., 2000), serve as a
site of protein sorting via recognition of
ubiquitylated proteins. Several adaptor
protein families bind PI(3)P through
conserved modules termed lipid-binding
domains, which include C2, FYVE, and
PX domains (Hammond and Balla,
2015). One such adaptor protein that
functions in protein sorting is Tollip. Tollip
can associate with ubiquitin, Tom1, and
clathrin (Yamakami et al., 2003) and also
harbors a C2 domain that binds PI(3)P
(Ankem et al., 2011). Tollip plays an
essential role in degradation of proteins
that are ubiquitylated (Katoh et al.,2004), serves in sorting of the inter-
leukin-1 receptor (IL-1R) (Brissoni et al.,
2006), and can regulate polyglutamine
protein removal (Lu et al., 2014). In addi-
tion to the lipid-binding properties of its
C2 domain, the Tollip C2 domain can
also bind ubiquitin as can its CUE domain.
Further, Tollip contains a Tom1-binding
domain (TBD) that mediates association
with the adaptor protein Tom1.
Tom1 is an adaptor protein containing
VHS and GAT domains. Previous work
has suggested that cargo such as IL-1R
is handed off from Tollip to Tom1 to facil-
itate endosomal degradation machinery
recruitment (Brissoni et al., 2006). This
suggested that Tollip- and Tom1-depen-
dent trafficking functioned in parallel or
in place of the ESCRT-0 complex (Shields
and Piper, 2011). Despite the elegant
biochemical and cell biology studies pre-
viously performed, little information on
the molecular interactions governing
Tom1 and Tollip interactions has been
elucidated. Tom1 has been shown to
interact with Tollip using its GAT domain,
but the biophysical basis of this associa-
tion was previously unknown.
Capelluto and colleagues present
exciting structural and cellular evidence
that Tollip binding to PI(3)P is regulated
by a Tom1-Tollip interaction mediated
by the Tom1 GAT domain and the Tollip
TBD (Xiao et al., 2015). The authors
employ NMR to solve the structural basis
of Tollip-Tom1 interactions. These studies
elucidated that the TBD of Tollip was not
folded in its native state, but the TBD N
terminus underwent structural perturba-
tions upon interaction with the Tom1
GAT domain. Tollip TBD was intrinsically
disordered as evidenced by NMR and cir-Structure 23, October 6, 2015cular dichroism analysis, and structural
changes in the TBDwere specific to asso-
ciation with the Tom1 GAT domain as
other ligands of Tollip, ubiquitin and PI(3)
P, did not alter the NMR spectrum. Upon
association with the Tom1 GAT domain,
the first 22 amino acids of the Tollip TBD
were ordered whereas the C-terminal
half of the TBD was still disordered. Simi-
larly, the Tom1GAT domain was shown to
undergo structural changes upon associ-
ation with the Tollip TBD, which was most
significant in the first and second a helices
of the GAT domain. Mutations of residues
implicated in the interaction of the Tom1
GAT domain or Tollip TBD via NMR
analysis abrogated the sub-nanomolar
apparent Kd of the interaction. The au-
thors demonstrated the importance of
this interaction in cell culture as mutagen-
esis of residues mediating the Tom1
GAT-Tollip TBD interaction disrupted
Tom1 localization to Tollip-containing
vesicles. Appropriate controls were
included to demonstrate that the Tom1
and Tollip interaction was independent
of the ability of Tollip to bind PI(3)P on
early endosomes.
Strikingly, the binding of Tollip C2
domain to PI(3)P was greatly diminished
when the Tollip TBD associated with the
Tom1 GAT domain. This displacement
was specific to the association of Tollip
and Tom1 as PI(3)P binding by a control
PI(3)P-binding domain was not affected.
Mutation of residues that mediate the
TBD-GAT domain interactions did not
significantly affect the Tollip C2 domain
PI(3)P binding, again supporting the
notion that the TBD-GAT domain interac-
tion can modulate Tollip C2 domain affin-
ity for PI(3)P. Capelluto and colleaguesª2015 Elsevier Ltd All rights reserved 1781
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Previews(Xiao et al., 2015) also showed that the
Tom1 GAT domain was able to interact
with the Tollip C2 domain, suggesting
that the GAT domain can form a complex
with Tollip through both TBD and C2
domain association. However, the associ-
ation of the GAT domain directly with the
Tollip C2 domain only lead to minor
perturbation of Tollip C2 domain PI(3)P
binding. This strongly suggested the
TBD-GAT domain interaction is the main
site that regulates the dissociation of
Tollip from PI(3)P containing membranes.
Lipid binding can be regulated by
structural changes in proteins, which
include regulatory mechanisms such as
protein phosphorylation, metal ion bind-
ing (e.g., calcium), changes in desolva-
tion, and protein-protein interactions
(Cho and Stahelin, 2005). To the best of
my knowledge, Capelluto and colleagues
demonstrate for the first time that pro-
tein-protein induced folding changes in
a membrane bound protein can modulate
the affinity for a lipid (Xiao et al., 2015).
This mode of regulation is quite inter-
esting, as conformational changes in
one domain (TBD) mediate lipid affinity
in a second modular domain (C2). While1782 Structure 23, October 6, 2015 ª2015 Elthe structural basis of dampened PI(3)P
affinity by the Tollip C2 domain under
these conditions is unknown, this is un-
doubtedly an important mechanistic
question to be answered in this trafficking
field. Perhaps future structural studies by
these authors will resolve how the Tollip
TBD-induced folding of the N terminus
mediates changes in the C2 domain’s
ability to bind lipid.
Capelluto and colleagues have also
answered several timely questions re-
garding endosomal trafficking and sorting
of cargo, and they propose a logical
model that accounts for protein handoff
in this pathway (Xiao et al., 2015). While
the predictive power of these types of
structural phenomena seen for the Tom1
GAT and Tollip TBD are still lacking, this
innovative study should serve as a model
for how other multimodular domain pro-
teins function in protein trafficking and
cellular signaling.REFERENCES
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